Company logo

Redona Therapeutics

Research
Biotechnology research

Redona Therapeutics information

Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

Employees

Edward Darr
VP Finance & Operations
Chris Mayo
Scientist
Meghan Melberg
Research Associate
Dillon Hawley
Scientist

Looking for a particular Redona Therapeutics Employee?

Redona Therapeutics' financial review

Total Funding

80M

Employees

19

Last Funding Round

15M


Employees

Edward Darr
VP Finance & Operations
Chris Mayo
Scientist
Meghan Melberg
Research Associate
Dillon Hawley
Scientist

Looking for a particular Redona Therapeutics Employee?

Redona Therapeutics' financial review

Total Funding

80M

Employees

19

Last Funding Round

15M


Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Represents linkedin prospector

See why over 1,000,000

people joined Apollo last year

Evolve your team’s engagement & intelligence today.